Unique balanced chromosome abnormalities in treatment-related myelodysplastic syndromes and acute myeloid leukemia: Report from an international workshop

Genes Chromosomes and Cancer

Volumn 33, Issue 4, 2002, Pages 413-423

  Olney, Harold J ^a,e   Mitelman, Felix ^b   Johansson, Bertil ^b   Mrózek, Krzysztof ^c   Berger, Roland ^d   Rowley, Janet D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c OHIO STATE UNIVERSITY   (United States)

^d INSERM   (France)

^e Blood Bank ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GYRASE INHIBITOR; IDARUBICIN; IFOSFAMIDE; LOMUSTINE; MELPHALAN; MITOXANTRONE; PROCARBAZINE; TENIPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; BREAST CANCER; CHILD; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME BAND; CHROMOSOME REARRANGEMENT; CONFERENCE PAPER; ENDOMETRIUM CANCER; FEMALE; HODGKIN DISEASE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SOLID TUMOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME BREAKAGE; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; SURVIVAL; TRANSLOCATION, GENETIC;

EID: 0036197441     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10045     Document Type: Conference Paper

References (46)

1. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on balanced rearrangements
2. The clinical significance of karyotype in acute myelogenous leukemia
3. Trisomy 11 in myelodysplastic syndrome-derived acute myeloblastic leukaemias
4. Preliminary data on the in vitro proliferation pattern and karyotypic characteristics in cells of patients with ANLL
5. World Health Organization classification of the acute leukemias and myelodysplastic syndrome
6. Detection of trisomy 8 on blood smears using fluorescence in situ hybridization
7. Translocation (2;3)(p22;q28) is associated with myeloid disorders
8. Acute nonlymphocytic leukemia with narrow eosinophilia and chromosome 16 abnormality: A report of 18 cases
9. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia
10. Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia
11. Hematologic manifestations associated with deletions of the long arm of chromsome 20
12. An acquired Robertsonian translocation dic(14;14)(p11;p11) in a patient with a myelodysplasic syndrome following treatment of multiple myeloma
13. Favorable cytogenetic abnormalities in secondary leukemia
14. Subtle abnormalities in the short arm of chromosome 11 in acute myeloid leukemia
15. International scoring system for evaluating prognosis in myelodysplastic syndromes
16. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
17. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997
18. Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites
19. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis
20. Cytogenetic polyclonality in hematologic malignancies
21. Therapy-related leukemia and myelodysplastic syndrome: Clinical, cytogenetic, and prognostic features
22. Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: Report from an International Workshop
23. Cytogenetic and fluorescence in situ hybridization analyses of hematologic malignancies in Korea
24. Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine
25. The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex
26. Clinical importance of cytogenetics in acute myeloid leukaemia
27. Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French-American-British (FAB) Cooperative Group criteria
28. Chromosome 16q, eosinophilia and leukemia
29. Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation
30. Clinical and cytogenetic significance of myelodyplastic syndromes with disease evolution
31. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary, myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings
32. Secondary or therapy-related MDS and AML and their chromosome aberrations: Important to study but difficult to establish causality
33. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation
34. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821
35. International Workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: Overview report
36. Prognostic factors and scoring systems in myelodysplastic syndromes
37. 3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia
38. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group study
39. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes
40. Therapy-related myeloid leukemia
41. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: A multicentric study in Japan
42. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma
43. dic(5;17): A recurring abnormality in malignant myeloid disorders associated with mutations of TP53